Michael Backus is the new president and CEO of Oswego (N.Y.) Health.
Category: ROOT
Base salaries for 14 physician specialties
According to the “2022 Review of Physician and Advanced Practitioner Recruiting Incentives” provided by AMN Healthcare’s physician recruiting firm Merritt Hawkins, orthopedic surgery offers the highest average base salary while pediatrics offers the lo…
Gastro Health acquires Washington practice with endoscopy center
Gastro Health acquired Gastroenterology Associates in Olympia, Wash.
Top 20 outpatient prescription medications
Atorvastatin calcium makes up 2.8 percent of outpatient prescription medication claims, according to a Dec. 30 report from Definitive Healthcare.
Physician pays $90K to settle false billing allegations
Cypress, Texas-based podiatrist Amr El-Khashab, DPM, agreed to pay $90,000 to resolve allegations he submitted false claims, the U.S. Justice Department said Jan. 3.
Kootenai suffers 2022 losses but expects bounce-back to profit in 2023
Coeur d’Alene, Idaho-based Kootenai Health is projecting full-year 2022 losses of approximately $45 million but is also forecasting a return to profit this year and beyond, the healthcare system reported in a filing Jan. 4.
New study gives truth to trope: Women are more empathetic
Women have long been considered the more empathetic gender. New research confirms that notion, Fortune reported Dec. 28.
1 Pennsylvania ZIP code saw 885% hike in buprenorphine use
The 155 ZIP code, which encompasses Somerset, Pa., noted an 885 percent increase in hospitals and pharmacies dispensing one opioid use disorder treatment from 2010 to 2020, one study found.
OSF's most impactful innovation projects of 2022
In 2022, OSF Innovation and OSF OnCall, the digital health divisions of Peoria, Ill.-based OSF HealthCare, launched 10 different initiatives using digital technologies and data with the aim of providing more convenient access and improved patient outco…
12 blood pressure drugs back-ordered, partly because of carcinogen
Three drugmakers each have four blood pressure drugs in short supply after some were recalled in 2022 because of the presence of nitrosamine, which the FDA has labeled as a “probable human carcinogen.”
